Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis

Figure 4

Effect and safety of anticoagulant with different doses of enoxaparin (1.0 mg/kg q 12 h in the experimental group and 1.5 mg/kg qd in the control group): (a) analysis of recanalization rate; (b) bleeding events; (c) other adverse events.

(a)

(b)

(c)